Company Medican Enterprises, Inc.

MDCN

US58464T2024

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:59:07 09/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.	CI
2021	Medican Enterprises, Inc. acquired 49% stake in R & B Property Development LLC.	CI

Medican Enterprises, Inc. is engaged in residential and commercial real estate investment and development. The Company has relationships with equity suppliers, such as individual, commercial and institutional sources. The Company is specialized in value-added investment and development in A location in urban infill areas. The Companyâs subsidiary, Immediate Properties LLC, is a real estate company. Immediate Properties LLC is engaged in multifamily, retail, office, mixed-use, adaptive re-use of industrial buildings and historic renovations. Its investment portfolio includes properties across Northern and Southern California, Atlanta, and Nevada. The Company invests in California and other select metro areas.

Number of employees: 3

USD in Million	2020	Weight	2021	Weight	Delta
Real Estate Investment and Development 100.0 %	1	100.0 %	4	100.0 %	+283.99%

USD in Million	2020	Weight	2021	Weight	Delta
United States 100.0 %	1	100.0 %	4	100.0 %	+283.99%

Managers	Title	Age	Since
Mitchell Xavier CEO	Chief Executive Officer	-	-
Kenneth Williams CHM	Chairman	52	25/13/25

Members of the board	Title	Age	Since
Kenneth Williams CHM	Chairman	52	25/13/25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	38,944,976,286	38,555,526,523 ( 99.00 %)	0	99.00 %

Name	Equities	%	Valuation
Delbert Riley 5.100 %	255,000	5.100 %	- $

Medican Enterprises, Inc.

6320 Canoga Avenue Suite 1564

91367, Woodland Hills

+800-416-8802

http://www.medicaninc.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
MEDICAN ENTERPRISES, INC.	0.00%	38.94K
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals